COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,577 Articles (22,415 medRxiv, 8,162 bioRxiv)

Most recent first Previous |  Page 411: Articles 4101-4110  | Next

Peruvian National Survey of Mental Health and Service Utilization in the third year of the COVID-19 pandemic: Protocol for a nationally representative multistage survey
Cruz, V. O., Pariamachi, A., Napanga, N., Pena, B., Gamboa, L., Gonzales, C., Delgado, P., Burela, P. A., Villa-Palomino, J., Valentin, L., Zuniga, D., Quispe, O., Lopez, P., Alcantara, J., Bonilla, N., Anton, S., Gutierrez, M., Diaz, C., Claux, J., Gonzales, A., Vivar, R., Lobe, G., Contreras, E., Mahr, B., Pampamallco, M., Salazar, S., Santos, M., Valentin, V., Arias, J. P., Alvarez, M., Amaro, C., Calderon, K., Canchis, J., Carbajal, F., Chire, J., Correa, L., Hermoza, L., Moron, G., Palomino, C., Ramirez, R., Rojas, E., Arevalo, M., Arellano, C., Herrera, V., Ricardi, J., Gupio, G., Jaramillo, O., Clapes, C., Cerna, E., Antunez, M., Luna, F., Saavedra, A., Carbajal, S., Vega, F., Ruiz, P., Saavedra, J., Luna, E., Del-Campo, J., Familiar-Lopez, I., Ametaj, A. A., Copeland, W. E., Anthony, J., Nishimura, R., Tiemeier, H., Gelaye, B.
10.1101/2023.02.22.23286197 — Posted: 2023-02-23
A unique cytotoxic CD4+ T cells signature defines critical COVID-19
Baird, S., Ashley, C. L., Marsh-Wakefield, F., Alca, S., Ashhurst, T. M., Ferguson, A. L., Lukeman, H., Counoupas, C., Post, J. J., Konecny, P., Bartlett, A., Martinello, M., Bull, R. A., Lloyd, A., Grey, A., Hutchings, O., Palendira, U., Britton, W. J., Steain, M., Triccas, J. A.
10.1101/2023.02.17.23286059 — Posted: 2023-02-23
Evidence of Leaky Protection Following COVID-19 Vaccination and SARS-CoV-2 Infection in a US Correctional Facility Population
Lind, M. L., Dorion, M., Houde, A. J., Lansing, M., Lapidus, S., Thomas, R., Yildirim, I., Omer, S. B., Schulz, W. L., Andrews, J. R., Hitchings, M. D., Kennedy, B. S., Richeson, R. P., Cummings, D. A., Ko, A. I.
10.1101/2023.02.17.23286049 — Posted: 2023-02-23
Multilevel determinants of Covid-19 vaccine hesitancy and undervaccination among marginalized populations in the United States: A scoping review
Newman, P. A., Nyoni, T., Allan, K., Fantus, S., Dinh, D., Tepjan, S., Reid, L., Guta, A.
10.1101/2023.02.23.23286342 — Posted: 2023-02-23
Longitudinal Humoral and Cell-Mediated Immune Responses in a Population-Based Cohort in Zurich, Switzerland between March and June 2022 - Evidence for Protection against Omicron SARS-CoV-2 Infection by Neutralizing Antibodies and Spike-specific T cell responses
Zens, K. D., Llanas-Cornejo, D., Menges, D., Fehr, J., Munz, C., Puhan, M., Frei, A.
10.1101/2023.02.20.23286166 — Posted: 2023-02-23
Event Rate and Predictors of Post-Acute COVID-19 Sequalae and the Average Time to Diagnosis in General Population
MUTHUKA, J. K., M, C. M., Mativo, J. N., Nabaweesi, R., Kiptoo, M. K., Oluoch, K. J.
10.1101/2023.02.23.23286336 — Posted: 2023-02-23
Which lockdowns are the best lockdowns? Optimal interventions and the trolley problem in heterogeneous populations
Kollepara, P. K., Chisholm, R. H., Kiss, I. Z., Miller, J. C.
10.1101/2023.02.18.23286135 — Posted: 2023-02-23
Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020-2022
Solastie, A., Nieminen, T., Ekstrom, N., Nohynek, H., Lehtonen, L., Palmu, A. A., Melin, M.
10.1101/2023.02.17.23286042 — Posted: 2023-02-23
Possible Role of P-selectin Adhesion in Long-COVID: A Case of Recovery After Long-COVID
Tarasev, M., Gao, X., Ferranti, M., Zaidi, A., Hines, P.
10.1101/2023.02.16.23285993 — Posted: 2023-02-23
Examining the governance arrangements for healthcare worker COVID-19 protection in Kenya: A Scoping Review
Kazungu, J., Kagwanja, N. N., Wang, H., Chuma, J., Munge, K.
10.1101/2023.02.22.23286303 — Posted: 2023-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).